Authors
Jing Zhou, J Wu, B Li, Dongfeng Liu, Jie Yu, X Yan, Suilan Zheng, J Wang, Lingling Zhang, F He, Qiannan Li, A Chen, Y Zhang, X Zhao, Yi Guan, J Yan, J Ni, MA Nobrega, Bob Löwenberg, Ruud Delwel, PJM Valk, A Kumar, L Xie, DG Tenen, Guochang Huang, QF Wang
Publication date
2014/7
Journal
Leukemia
Volume
28
Issue
7
Pages
1436-1448
Publisher
Nature Publishing Group
Description
Mixed lineage leukemia (MLL) fusion proteins directly activate the expression of key downstream genes such as MEIS1, HOXA9 to drive an aggressive form of human leukemia. However, it is still poorly understood what additional transcriptional regulators, independent of the MLL fusion pathway, contribute to the development of MLL leukemia. Here we show that the transcription factor PU. 1 is essential for MLL leukemia and is required for the growth of MLL leukemic cells via the promotion of cell-cycle progression and inhibition of apoptosis. Importantly, PU. 1 expression is not under the control of MLL fusion proteins. We further identified a PU. 1-governed 15-gene signature, which contains key regulators in the MEIS-HOX program (MEIS1, PBX3, FLT3, and c-KIT). PU. 1 directly binds to the genomic loci of its target genes in vivo, and is required to maintain active expression of those genes in both normal …
Total citations
20142015201620172018201920202021202220232024266109566321
Scholar articles